Aug. 19 at 11:57 AM
$TIVC The potential of this stock is incredible, IMO. Tivic Health's Entolimod drug is currently in development for the treatment of Acute Radiation Syndrome (ARS). The company acquired the exclusive worldwide rights to Entolimod. Tivic Health's TLR5 program, including its lead candidate Entolimod™, has received funding from U.S. government agencies, such as BARDA, NASA, and the DoD. They had Discussions with the White House and FDA highlighted the potential military applications of the company's product candidates. Tivic is also developing medical devices for inflammatory, cardiac, and neurological disorders, including PTSD, an area of military interest. So, there is interest from the White House, FDA, and DoD agencies, with funding, which will generate demand for Tivic's products in the military sector (contracts/deals ).
